Drugs to Watch 2020
Market intelligence reports
BioWorld - Monday, March 30, 2020
» Regulatory actions for Feb. 4, 2020
Looking to read the full article? Subscribe to BioWorld.
Regulatory actions for Feb. 4, 2020
February 4, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Anavex, Biocryst, Glycomimetics.
Already a subscriber?